A scientist pipetting media in a laboratory biosafety cabinet.

Pioneering the use of CRISPR in molecular detection.

We are developing the first molecular detection method with digital-like features: on/off switches, easily programmable and massively scalable.

ABOUT US

Our Origins

The VedaBio team standing outside the office for a group photo.
A scientist using a multi-pipette to add media to wellplates.

Veda is derived from the Sanskrit word for the creation of knowledge. With our team of industry leading experts, we operate at the forefront of scientific innovation to push the limits of what’s possible in the field of molecular detection.

By combining the power of our platform with a strong focus on delivering products to solve real clinical and industrial needs, our goal is to provide access to true, actionable information previously unattainable with prior molecular detection methods.

Profil photo of VedaBio CEO, Frederic Sweeney
Frederic Sweeney, PhD
Director, President and CEO

Meet Our Team

Select a Category
All
Executive Leadership
Senior Leadership
Phil Belgrader, PhD
VP, Systems Integration
Jorge Bernate, PhD
Executive Director, Assay, Platform & Technology
Sally Brashears
VP, Intellectual Property
Andrea Bryan, PhD
Senior Director, Systems Engineering
Adria Curtis
Head of Human Resources
Kim Dorans
Director, Strategy & Corporate Development
Maurice Exner, PhD
Chief Operations Officer
Andrew Garst, PhD
Senior Director, Platform
& Application Development
Christine Ginocchio, PhD, MT
Chief Medical & Scientific Officer
Kristen Kanack, PhD
VP, Regulatory, Clinical & Quality
Haleigh Millward
Senior Director, Program Management
Frédéric Sweeney, PhD
President & CEO

Join Us

Interested in joining the VedaBio team? We’re hiring!

Board Members

Select a category
All
Board of Directors
Scientific Advisory Board
Frédéric Sweeney, PhD
President & CEO
Rashid Bashir, PhD
Co-Founder
Craig Asher
Managing Director, OMX Ventures
Nick Haft
Managing Director, OMX Ventures
Swetha Murali
Vice President, OMX Ventures (Board Observer)
Daniel Durocher, PhD
SAB Chair & SAB Member
Patrick Hsu, PhD
SAB Member
David Perlin, PhD
SAB Member

Contact us today.

Learn how the CRISPR Cascade™ Platform and our industry-leading discovery and development expertise opens up a universe of application potential.

Name Here, More
Director, and Title Name

Heading 1

Heading 2

Heading 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do

Block quote
  1. Item 1
  2. Item 2
  3. Item 3
  • Item A
  • Item B
  • Item C